Skip to content

Effect of calcium alginate-containing noodles on triglycerides. Placebo-controlled randomized double-blind crossover study.

Effect of calcium alginate-containing noodles on triglycerides. Placebo-controlled randomized double-blind crossover study. - Effect of calcium alginate-containing noodles on triglycerides.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000056513
Enrollment
12
Registered
2024-12-25
Start date
2024-11-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Sponsors

General Incorporated Association, Kendai Translational Research Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Males and females aged 18 years or older at the time of informed consent. In principle, those whose fasting blood triglyceride level at the time of screening test is less than 150mg/dL. Those who fully understand the purpose and safety of this research specified in the research cooperation consent form and have obtained consent.

Exclusion criteria

Exclusion criteria: Persons receiving treatment, medication, or lifestyle guidance from a doctor due to dyslipidemia or diabetes. Persons who regularly use medicines, health foods, or supplements that affect blood lipids. Those with serious illnesses, such as diabetes, liver disease, kidney disease, high blood pressure, ischemic heart disease, or digestive system disease, or those with a history of such illnesses. Those taking medicines or supplements that may affect glucose metabolism. Persons who have some kind of disease and are receiving medication and are deemed unsuitable as subjects by the research doctor. Persons whose HIV antigen/antibody, HBs antigen, HCV antibody, or syphilis test result was positive at the time of screening. Persons with obvious abnormalities found in hematological or biochemical tests. Those who are pregnant, wish to become pregnant during the test, or are breastfeeding. Persons who had difficulty collecting blood during the screening test. Persons whose triglyceride delta C3h (estimated TGCmax) is less than 30 mg/dL in the screening test. Persons who may experience allergic symptoms regarding the test noodles (flour, etc.)

Design outcomes

Primary

MeasureTime frame
The area under the curve (AUC, delta AUC) of the postprandial serum triglyceride. The serum triglyceride level C, delta C. The maximum concentration (Cmax, delta Cmax) of the postprandial serum triglyceride.

Countries

Japan

Contacts

Public ContactSatsuki Kimura

General Incorporated Association, Kendai Translational Research Center Clinical Research Department

kimura.ktrc@gmail.com0273954316

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026